[14C] and [13C] labellings from N-(2-diethylaminoethyl)-4-iodobenzamide, and N-(3-deimethylaminopropyl)-4-iodobenzamide, melanoma tracers

Article abstract of DOI:10.1002/jlcr.2580360813

N-(2-diethylaminoethyl)-4-iodobenzamide (I) and N-(3-dimethylaminopropyl)-4-iodobenzamide (II), recently developed in our laboratory, are promising agents for metastatic melanoma detection in nuclear medicine. In order to study their 'in vivo' metabolism,